✦ LIBER ✦

Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: A meta-analysis of clinical trials

✍ Scribed by De Rosa, Salvatore; Caiazzo, Gianluca; Torella, Daniele; Indolfi, Ciro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet glycoprotein IIb/IIIa inhibitor

✍ E. Boersma; R.A. Harrington; D.J. Moliterno 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Platelet glycoprotein IIb/IIIa inhibitor

✍ Eric Boersma; Robert A Harrington; David J Moliterno; Harvey White; Pierre Théro 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 128 KB

INCIDENCE RATES OF DEATH AND MAJOR CARDI

✍ Concetta Crivera; Shih-Yin Chen; Michael Stokes; Luke Boulanger; Jeffrey Schein 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

A Meta-analysis of 64-section Coronary C

✍ Takakuwa, Kevin M.; Keith, Scott W.; Estepa, Adrian T.; Shofer, Frances S. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Acute coronary syndromes in human immuno

✍ D'Ascenzo, F.; Cerrato, E.; Biondi-Zoccai, G.; Moretti, C.; Omede, P.; Sciuto, F 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 134 KB

Low Molecular Weight Heparin and Unfract

✍ Mai-Trang Le Nguyen; Frederick A. Spencer 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 176 KB